Reaktionsgleichung
[C:1]([C:3]1[CH:4]=[C:5]([NH:9][C:10](=[O:12])[CH3:11])[CH:6]=[CH:7][CH:8]=1)#[CH:2].[CH2:13]([O:15][C:16]([C:18]1[N:19]([CH3:25])[C:20](Br)=[N:21][C:22]=1[CH3:23])=[O:17])[CH3:14]>>[CH2:13]([O:15][C:16]([C:18]1[N:19]([CH3:25])[C:20]([C:2]#[C:1][C:3]2[CH:8]=[CH:7][CH:6]=[C:5]([NH:9][C:10](=[O:12])[CH3:11])[CH:4]=2)=[N:21][C:22]=1[CH3:23])=[O:17])[CH3:14]Komponenten
3
Versuchsvorschrift
The title compound, MS: m/e=326.8 (M+H+), was prepared in accordance with the general method of example 1b from N-(3-ethynyl-phenyl)-acetamide and 2-bromo-3,5-dimethyl-3H-imidazole-4-carboxylic acid ethyl ester.
Quellen und Nachweise
- ORD-Eintrag
- ord-1bd2c5e3b72542669212a35f908986fd
- Quelldatensatz
- uspto-grants-2004_03
- Patentnummer
- US06706707B2
Verknüpfte Notizen
Wird geladen…